Platelet Serotonin Deficiencies: the Strasbourg Experience
Recruiting
Observational Study
Hemorrhagic Syndrome
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Hemorrhagic syndromes are investigated using algorithms established by reference centers and hemostasis societies.
The investigation of platelet dense granules (nucleotide and serotonin testing) is part of the second-line tests.
It can be performed in cases of platelet aggregation abnormalities in platelet-rich plasma (PRP) suggesting a secretion abnormality, or in cases where the latter is norm…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patient (≥ 18 years old)
* Treated at Strasbourg University Hospital for a hemorrhagic syndrome, suggesting a primary hemostasis abnormality and normal von Willebrand factor, during the period from January 1, 2023, to April 1, 2024.
Exclusion Criteria:
\- Refusal to pa…
Contacts